AgingResearch.News
Journal of the Endocrine Society

Weight loss outcomes with tirzepatide in women with and without self-reported polycystic ovary syndrome

By Ashley Kieran Clift, Daniel Reisel, Hans H. Johnson, Naveed A. Sattar, David R Huang
Figure 1. Kaplan-Meier estimates of cumulative probability of attaining thresholds of total body weight loss during follow-up in the cohort, stratified by self-reported polycystic ovary syndrome status; (A)…
Open the figure at full size
Figure 1. Kaplan-Meier estimates of cumulative probability of attaining thresholds of total body weight loss during follow-up in the cohort, stratified by self-reported…Kaplan-Meier estimates of cumulative probability of attaining thresholds of total body weight loss during follow-up in the cohort, stratified by self-reported polycystic ovary syndrome status; (A) 5% total body weight loss; (B) 10% total body weight loss; (C) 15% total body…Clift et al.
Cohort study of 54,114 peopleInterventions

10 months, declared ties to: Menwell, Abbott, AbbVie and 14 more

Paper

The paper

Ashley Kieran Clift, Daniel Reisel, Hans H. Johnson, Naveed A. Sattar, David R Huang

Menwell Limited

Journal of the Endocrine Society, 19 Aug 2026

doi.org/10.1210/jendso/bvag177PubMed 42634795

More on GLP-1 and incretin signalling